Ficus carica (Linn.) Leaf and Bud Extracts and Their Combination Attenuates Type-1 Diabetes and Its Complications via the Inhibition of Oxidative Stress.
Asmae El GhouiziDriss OusaaidHassan LaaroussiMeryem BakourAbderrazak AboulghaziRose Strutch SoutienChristopher HanoBadiaa LyoussiPublished in: Foods (Basel, Switzerland) (2023)
The current work was designed to evaluate the antioxidant activity and antidiabetic effect of Ficus carica L. extracts. For that, the leaves and buds of Ficus carica L. were analyzed to determine their polyphenolic and flavonoid contents and antioxidant activity. Diabetes was induced by a single dose of alloxan monohydrate (65 mg/kg body weight), then diabetic rats were treated with a dose of 200 mg/kg body weight of the methanolic extracts of Ficus carica leaves or buds or their combination for 30 days. Throughout the experiment, blood sugar and body weight were measured every 5 and 7 days respectively. At the end of the experiment, serum and urine were collected for analysis of alanine aminotransferase, aspartate aminotransferase, total cholesterol, triglycerides, creatinine, uric acid, urea, proteins, sodium, potassium, and chloride. Pancreas, liver, and kidney were removed to estimate catalase, glutathione peroxidase, and glutathione activities; lipid peroxidation products were also determined. The results obtained revealed that alloxan has induced hyperglycemia, increased liver and renal biomarkers levels, reduced antioxidative enzymes, and induced lipid peroxidation. However, the treatment with Ficus carica leaf and bud extracts, especially their combination, has attenuated all pharmacological perturbations induced by alloxan.
Keyphrases
- body weight
- diabetic rats
- oxidative stress
- uric acid
- type diabetes
- metabolic syndrome
- cardiovascular disease
- glycemic control
- dna damage
- ischemia reperfusion injury
- fatty acid
- high glucose
- induced apoptosis
- hydrogen peroxide
- risk factors
- nitric oxide
- signaling pathway
- drug induced
- single cell
- combination therapy
- replacement therapy
- newly diagnosed
- skeletal muscle
- smoking cessation